Newron Pharmaceuticals S.p.A.
NWPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $21,394 | -$16,200 | -$17,493 | -$14,901 |
| Dep. & Amort. | $192 | $201 | $202 | $209 |
| Deferred Tax | $0 | $0 | $402 | -$2,514 |
| Stock-Based Comp. | $256 | $197 | $480 | $762 |
| Change in WC | -$37,753 | $1,636 | -$882 | $1,752 |
| Other Non-Cash | -$1,703 | $4,026 | $6,199 | $3,247 |
| Operating Cash Flow | -$17,614 | -$10,140 | -$11,092 | -$11,445 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | -$11 | -$18 | -$20 |
| Net Acquisitions | $0 | -$3,257 | $299 | -$8,440 |
| Inv. Purchases | -$1,875 | -$981 | -$3,040 | -$1,698 |
| Inv. Sales/Matur. | $5,046 | $4,238 | $2,741 | $10,138 |
| Other Inv. Act. | $0 | $3,257 | -$299 | $8,440 |
| Investing Cash Flow | $3,158 | $3,246 | -$317 | $8,420 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $15,000 |
| Stock Issued | $15,414 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$363 | -$192 | -$186 | -$169 |
| Financing Cash Flow | $15,051 | -$192 | -$186 | $14,831 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $595 | -$7,086 | -$11,595 | $11,806 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,338 | $13,424 | $25,019 | $13,213 |
| End Cash | $6,933 | $6,338 | $13,424 | $25,019 |
| Free Cash Flow | -$17,627 | -$10,151 | -$11,110 | -$11,465 |